# Orphenadrine Citrate

NDC: 0591-3222
Generic name: Orphenadrine Citrate
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20100708

FDA application: ANDA084779

## Active ingredients

- ORPHENADRINE CITRATE: 30 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0591-3222"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0591-3222
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aec8ad3a-f717-4e74-b7b9-19debdaad79a